Merck Global Health Innovation Fund (GHIF) is a corporate venture capital fund headquartered in Whitehouse Station, New Jersey. It was launched by Merck in 2010 with the goal of increasing Merck's strategic position through digital healthcare technology investments. The company makes capital investments between $5-7 million, on average, to global digital healthcare technology companies. It has invested in the bid data, e-clinical trails, healthcare analytics, artificial intelligence, care management, diagnostic technology, therapy planning, cloud computing, and SaaS sectors.
In 2019, it was reported that Merck GHIF managed a $500 million evergreen fund. It has invested in over 40 digital healthcare companies and has reported 14 exits.